Over the last 7 days, the Healthcare Services industry has risen 1.4%, driven by gains from Sinopharm Group of 5.4%. Meanwhile, Concord Healthcare Group actually underperformed within the industry, shrinking 7.8% in the last week. In contrast, the industry has lost 31% in the last 12 months. As for the next few years, earnings are expected to grow by 15% per annum.
Has the Hong Kong Healthcare Services Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 08 Aug 2024 | HK$231.0b | HK$828.1b | HK$12.7b | 10.8x | 18.3x | 0.3x |
Sat, 06 Jul 2024 | HK$241.3b | HK$818.8b | HK$12.5b | 10.9x | 19.3x | 0.3x |
Mon, 03 Jun 2024 | HK$253.0b | HK$823.0b | HK$12.5b | 12.6x | 20.2x | 0.3x |
Wed, 01 May 2024 | HK$254.9b | HK$823.4b | HK$12.6b | 11.9x | 20.3x | 0.3x |
Fri, 29 Mar 2024 | HK$237.3b | HK$822.4b | HK$13.2b | 11.8x | 18x | 0.3x |
Sun, 25 Feb 2024 | HK$248.9b | HK$815.2b | HK$12.0b | 14.6x | 20.7x | 0.3x |
Tue, 23 Jan 2024 | HK$221.0b | HK$814.9b | HK$12.0b | 15.1x | 18.4x | 0.3x |
Thu, 21 Dec 2023 | HK$236.2b | HK$819.3b | HK$12.5b | 15.3x | 19x | 0.3x |
Sat, 18 Nov 2023 | HK$254.6b | HK$810.4b | HK$12.2b | 14.2x | 20.9x | 0.3x |
Mon, 16 Oct 2023 | HK$289.7b | HK$802.6b | HK$12.3b | 13.4x | 23.5x | 0.4x |
Wed, 13 Sep 2023 | HK$285.1b | HK$805.3b | HK$12.7b | 13.1x | 22.4x | 0.4x |
Fri, 11 Aug 2023 | HK$291.7b | HK$782.6b | HK$11.5b | 10.5x | 25.4x | 0.4x |
Sun, 09 Jul 2023 | HK$320.7b | HK$803.0b | -HK$157,748,588.00 | 11.8x | -2032.9x | 0.4x |
Tue, 06 Jun 2023 | HK$316.8b | HK$775.9b | HK$816.7m | 11.7x | 387.9x | 0.4x |
Thu, 04 May 2023 | HK$333.7b | HK$799.5b | HK$1.3b | 11.5x | 258.6x | 0.4x |
Sat, 01 Apr 2023 | HK$328.3b | HK$798.9b | HK$2.4b | 16.6x | 135.3x | 0.4x |
Mon, 27 Feb 2023 | HK$311.5b | HK$777.1b | HK$3.4b | 16.2x | 91.5x | 0.4x |
Wed, 25 Jan 2023 | HK$310.6b | HK$793.8b | HK$3.5b | 16.2x | 89.1x | 0.4x |
Fri, 23 Dec 2022 | HK$288.8b | HK$768.7b | HK$3.0b | 14x | 97.6x | 0.4x |
Sun, 20 Nov 2022 | HK$266.1b | HK$756.9b | HK$2.3b | 13.9x | 115.2x | 0.4x |
Tue, 18 Oct 2022 | HK$197.6b | HK$661.1b | -HK$2,214,208,525.00 | 13.1x | -89.2x | 0.3x |
Thu, 15 Sep 2022 | HK$208.7b | HK$684.7b | -HK$2,362,790,592.00 | 16.2x | -88.3x | 0.3x |
Sat, 13 Aug 2022 | HK$225.8b | HK$691.8b | -HK$6,925,686,209.00 | 17.7x | -32.6x | 0.3x |
Mon, 11 Jul 2022 | HK$242.7b | HK$696.9b | -HK$6,976,338,004.00 | 17.3x | -34.8x | 0.3x |
Wed, 08 Jun 2022 | HK$210.1b | HK$698.4b | -HK$6,174,652,313.00 | 17x | -34x | 0.3x |
Fri, 06 May 2022 | HK$195.1b | HK$692.5b | -HK$6,929,499,017.00 | 17.4x | -28.2x | 0.3x |
Sun, 03 Apr 2022 | HK$210.5b | HK$729.8b | -HK$4,922,008,602.00 | 16.5x | -42.8x | 0.3x |
Tue, 01 Mar 2022 | HK$253.7b | HK$723.4b | -HK$5,047,201,770.00 | 18.2x | -50.3x | 0.4x |
Thu, 27 Jan 2022 | HK$244.2b | HK$718.3b | -HK$5,301,807,039.00 | 16.9x | -46.1x | 0.3x |
Sat, 25 Dec 2021 | HK$244.3b | HK$712.2b | -HK$5,429,791,151.00 | 17.8x | -45x | 0.3x |
Mon, 22 Nov 2021 | HK$289.1b | HK$709.5b | -HK$5,408,577,447.00 | 17.6x | -53.5x | 0.4x |
Wed, 20 Oct 2021 | HK$327.8b | HK$694.1b | -HK$5,375,192,507.00 | 16.7x | -61x | 0.5x |
Fri, 17 Sep 2021 | HK$311.9b | HK$693.6b | -HK$5,446,906,257.00 | 16.7x | -57.3x | 0.4x |
Sun, 15 Aug 2021 | HK$464.7b | HK$689.6b | -HK$5,408,746,530.02 | 16.8x | -85.9x | 0.7x |
-85.9x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | -2.03% | |
Healthcare | 1.43% | |
Healthcare Services | 0.0084% | |
Healthcare Distributors | 2.56% | |
Managed Healthcare | 0% | |
Healthcare Services | -2.06% | |
Healthcare Facilities | -3.54% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1099 Sinopharm Group | HK$19.36 | 5.4% +HK$3.1b | -11.2% | PE6.3x | |
6078 Hygeia Healthcare Holdings | HK$21.75 | 3.3% +HK$442.1m | -51.8% | PE18.5x | |
9860 Adicon Holdings | HK$9.93 | 5.2% +HK$355.6m | -21.7% | PE28.2x | |
1951 Jinxin Fertility Group | HK$2.62 | 4.0% +HK$274.9m | -37.8% | PE19.2x | |
9885 YSB | HK$7.94 | 4.2% +HK$205.1m | -84.6% | PS0.3x |